M. Patrick Stagg

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6,633 patients from 27 randomized trials

Stefano Pasquali, J D Maqueo, Jorge Espino Vela et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1998 · 473 citations

Medicine, Oncology, Pharmacology +16

The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma

Michael Jeffers, Gerard M. O'Dowd, Hugh Mulcahy et al. · The Journal of Pathology · 1994 · 242 citations

Medicine, Oncology, Pathology +17

Clinical pharmacokinetics of 3′-azido-3′-deoxythymidine (zidovudine) and catabolites with formation of a toxic catabolite, 3′-amino-3′-deoxythymidine

M. Patrick Stagg, E M Cretton, Lauren B. Kidd et al. · Clinical Pharmacology & Therapeutics · 1992 · 93 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +6

A phase III trial of high-dose cytosine arabinoside with or without etoposide in relapsed and refractory acute myelogenous leukemia. A Southeastern Cancer Study Group trial.

William R. Vogler, Dean L. McCarley, M. Patrick Stagg et al. · PubMed · 1994 · 64 citations

Medicine, Oncology, Pharmacology +16

One-hour paclitaxel plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicentre, phase II trial

John D. Hainsworth, Walter J. Urba, Jeremy K. Hon et al. · European Journal of Cancer · 1998 · 43 citations

Medicine, Oncology, Pharmacology +11